The FDA has approved Zurzuvae, the first-ever pill for treating postpartum depression. Here’s how it works.
of postpartum depression are multi-factorial and include everything from genetics and hormonal changes to a strained social support system, pregnancy complications and financial stress. Having a personal or family history of a mental health issue like depression or bipolar disorder can increase a person’s risk, as can having a baby with a health complication, going through with an unwanted pregnancy, experiencing difficulty with breastfeeding, or having problems with a partner.
Zuranolone is a neuroactive steroid that affects the primary neurotransmitter in the brain, binding to receptors and boosting activity that can restore dysregulated networks“That’s the hypothesis of why it could be impacting depression in the perinatal period,” says McMahon.
The women were split up into two groups: 98 took 50 milligrams of zuranolone once daily for 14 days and the other 98 took a placebo. By day 15, 57% of those who took the pill said their depressive symptoms had improved by at least 50%, and 26.9% achieved remission.develop depression during pregnancy or post-delivery.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Read more »
First-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Read more »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Read more »
First Pill for Postpartum Depression Is Approved by FDAThe pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial.
Read more »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Read more »
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
Read more »